AVITA Medical (NASDAQ:RCEL) Earns “Buy” Rating from D. Boral Capital
D. Boral Capital restated their buy rating on shares of AVITA Medical (NASDAQ:RCEL – Free Report) in a research report report published on Friday morning,Benzinga reports. D. Boral Capital currently has a $22.00 price objective on the stock. A number of other research firms have also recently weighed in on RCEL. Lake Street Capital decreased […]
D. Boral Capital restated their buy rating on shares of AVITA Medical (NASDAQ:RCEL – Free Report) in a research report report published on Friday morning,Benzinga reports. D. Boral Capital currently has a $22.00 price objective on the stock. A number of other research firms have also recently weighed in on RCEL. Lake Street Capital decreased […]
